ShareValue scores for 001360.KO: Valuation 39, Quality 13, Growth 20, Health 38.

001360.KO
KRX

Samsung Pharm

₩1,302.00(-0.61%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-12% to 11%
Valuation
39
Overvalued
Price vs Value
Quality
13
Weak
Business Strength
Growth
20
Weak
Revenue & Earnings
Health
38
Stressed
Financial Stability
Momentum
44
Neutral
Price Trend

Company Details

About

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, cold medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 and is headquartered in Hwaseong-si, South Korea.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026